Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:20 a.m. ET on Wednesday, June 4, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, ...

The Dow Jones Industrial Average is climbing Friday afternoon with shares of Walmart and Amgen seeing positive gains for the price-weighted average.

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

GTS Securities sliced its Amgen stake by over half, dumping 6,541 shares and leaving just 5,117 shares worth $1.3 million.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

Alan Berro of American Funds Washington Mutual focuses on buying good companies at a decent price, such as Amgen, Comcast, ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...